https://www.avient.com/company/sustainability/sustainability-report/people
At Avient, we recognize the immense benefits that a diverse team brings to our organization, including delivering better business outcomes.
https://www.avient.com/investor-center/news/polyone-associates-raise-over-15-million-united-way
said, "We're a very special place to work, and that's because of the talented and generous people on our team.
https://www.avient.com/company/sustainability/sustainability-report/people/diversity-inclusion/raise-avient
Since then, the team sponsored a holiday gift-wrapping event where associates could socialize and wrap gifts together, or enjoy the convenience of having their gifts wrapped by a volunteer while they worked.
https://www.avient.com/news/polyone-receives-bd-innovation-award
From design and material selection assistance to the development of value-optimizing polymer formulations, PolyOne effectively collaborated with BD’s R&D and design teams to provide world-class solutions and service.
https://www.avient.com/knowledge-base/case-study/auto-supplier-cuts-costs-painting-trim-parts
Working in close cooperation, technical teams from both companies identified a product within the OnColor™ FX Smartbatch portfolio as a potential answer.
https://www.avient.com/sites/default/files/2022-02/Q4 2021 Avient Earnings Release_0.pdf
See
Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments associated
with the Clariant Color Acquisition necessary to reflect Clariant Color adjusted results in all periods presented.
Three Months Ended
December 31,
Year Ended
December 31,
2021 2020 2021 2020
Sales:
Color, Additives and Inks $ 581.3 $ 525.8 $ 2,401.6 $ 1,502.9
Specialty Engineered Materials 228.2 190.6 918.9 708.8
Distribution 425.0 305.1 1,630.9 1,110.3
Corporate and eliminations (33.0) (24.5) (132.6) (79.9)
Sales $ 1,201.5 $ 997.0 $ 4,818.8 $ 3,242.1
Gross margin:
Color, Additives and Inks $ 164.5 $ 164.3 $ 727.5 $ 484.4
Specialty Engineered Materials 60.0 59.1 257.4 207.6
Distribution 36.5 32.4 155.8 124.0
Corporate and eliminations (7.9) (2.9) (41.1) (31.7)
Gross margin $ 253.1 $ 252.9 $ 1,099.6 $ 784.3
Selling and administrative expense:
Color, Additives and Inks $ 103.3 $ 106.8 $ 424.4 $ 303.6
Specialty Engineered Materials 31.2 28.7 125.4 113.2
Distribution 14.8 14.4 62.6 54.5
Corporate and eliminations 29.8 38.0 106.0 123.7
Selling and administrative expense $ 179.1 $ 187.9 $ 718.4 $ 595.0
Operating income:
Color, Additives and Inks $ 61.2 $ 57.5 $ 303.1 $ 180.8
Specialty Engineered Materials 28.8 30.4 132.0 94.4
Distribution 21.7 18.0 93.2 69.5
Corporate and eliminations (37.7) (40.9) (147.1) (155.4)
Operating income $ 74.0 $ 65.0 $ 381.2 $ 189.3
13
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current profitability
levels and how it may serve as a basis for future performance.
See Attachment 3 for a definition and summary of special items.
https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
See Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments
associated with the Clariant MB Acquisition necessary to reflect Clariant MB adjusted results in all periods presented.
Three Months Ended
Year Ended
Sales:
Color, Additives and Inks $ 525.8 $ 226.7 $ 1,502.9 $ 1,003.8
Specialty Engineered Materials 190.6 177.5 708.8 745.7
Distribution 305.1 272.4 1,110.3 1,192.2
Corporate and eliminations (24.5) (18.0) (79.9) (79.0)
Sales $ 997.0 $ 658.6 $ 3,242.1 $ 2,862.7
Gross margin:
Color, Additives and Inks $ 164.3 $ 73.9 $ 484.4 $ 338.4
Specialty Engineered Materials 59.1 47.7 207.6 200.2
Distribution 32.4 31.0 124.0 132.1
Corporate and eliminations (2.9) 0.7 (31.7) (13.5)
Gross margin $ 252.9 $ 153.3 $ 784.3 $ 657.2
Selling and administrative expense:
Color, Additives and Inks $ 106.8 $ 46.7 $ 303.6 $ 191.0
Specialty Engineered Materials 28.7 28.9 113.2 116.5
Distribution 14.4 14.0 54.5 56.7
Corporate and eliminations 38.0 43.2 123.7 136.2
Selling and administrative expense $ 187.9 $ 132.8 $ 595.0 $ 500.4
Operating income:
Color, Additives and Inks $ 57.5 $ 27.2 $ 180.8 $ 147.4
Specialty Engineered Materials 30.4 18.8 94.4 83.7
Distribution 18.0 17.0 69.5 75.4
Corporate and eliminations (40.9) (42.5) (155.4) (149.7)
Operating income $ 65.0 $ 20.5 $ 189.3 $ 156.8
11
Attachment 7
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current
profitability levels and how it may serve as a basis for future performance.
See Attachment 3 for a definition and
summary of special items.
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-news-release.pdf
See
Attachment 3 for a definition and summary of special items.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 2020 2021 2020
Sales:
Color, Additives and Inks $ 586.6 $ 493.8 $ 1,820.3 $ 977.1
Specialty Engineered Materials 233.6 174.1 690.7 518.2
Distribution 438.8 276.9 1,205.9 805.2
Corporate and eliminations (39.2) (20.3) (99.6) (55.4)
Sales $ 1,219.8 $ 924.5 $ 3,617.3 $ 2,245.1
Gross margin:
Color, Additives and Inks $ 172.1 $ 155.0 $ 563.0 $ 320.1
Specialty Engineered Materials 63.1 53.4 197.4 148.5
Distribution 39.9 30.8 119.3 91.6
Corporate and eliminations (19.7) (29.0) (33.2) (28.8)
Gross margin $ 255.4 $ 210.2 $ 846.5 $ 531.4
Selling and administrative expense:
Color, Additives and Inks $ 105.3 $ 104.5 $ 321.1 $ 196.8
Specialty Engineered Materials 31.4 28.7 94.2 84.5
Distribution 16.1 13.3 47.8 40.1
Corporate and eliminations 23.9 30.2 76.2 85.7
Selling and administrative expense $ 176.7 $ 176.7 $ 539.3 $ 407.1
Operating income:
Color, Additives and Inks $ 66.8 $ 50.5 $ 241.9 $ 123.3
Specialty Engineered Materials 31.7 24.7 103.2 64.0
Distribution 23.8 17.5 71.5 51.5
Corporate and eliminations (43.6) (59.2) (109.4) (114.5)
Operating income $ 78.7 $ 33.5 $ 307.2 $ 124.3
Earnings before interest, taxes, depreciation and
amortization (EBITDA):
Color, Additives and Inks $ 93.4 $ 76.8 $ 321.1 $ 171.3
Specialty Engineered Materials 39.6 32.2 127.0 86.7
Distribution 24.0 17.7 72.1 51.9
Corporate and eliminations (41.5) (56.7) (105.3) (108.3)
Other income, net 1.4 1.5 4.1 12.6
EBITDA $ 116.9 $ 71.5 $ 419.0 $ 214.2
13
Attachment 7
Avient Corporation
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(In millions, except per share data)
Senior management uses gross margin before special items and operating income before special items to assess performance
and allocate resources because senior management believes that these measures are useful in understanding current profitability
levels and how it may serve as a basis for future performance.
See Attachment 3 for a definition and summary of special items.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Colorants and Formulations_Functional Additives for IVD Devices Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Available as concentrates or ready-to-use
formulations in a wide range of polymers
• Functionality and color can be combined in
one product for convenience
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Documentation support for approval or
transition to comply with (new) regulations
such as IVDR
APPLICATION BULLETIN
Healthcare use limitations apply—see below.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/sites/default/files/2020-10/antimicrobial-dental-case-study.pdf
The Avient team first
collaborated with this manufacturer to define the
specific requirements for the antimicrobial additive.
Then, the team researched the best combination of
additive and carrier resin for the application.
In a relatively short time,
the Avient team was able to formulate additives that
performed well at lower LDRs.